Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000115978 | SCV000149887 | uncertain significance | not provided | 2013-10-17 | criteria provided, single submitter | clinical testing | This variant is denoted CHEK2 IVS1-9C>G or c.-6-9C>G and multiple in silico programs predict that this substitution reduces the quality of an already weak natural splice acceptor site in intron 1. Therefore, the impact of this variant on splicing is not clear. Furthermore, CHEK2 IVS1-9C>G has not, to our knowledge, been published in the literature as a mutation or as a benign polymorphism. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI ESP Exome Variant Server, suggesting it is not a common benign variant in these populations. Based on the current information, we cannot predict whether CHEK2 IVS1-9C>G is a rare, benign variant or a pathogenic mutation. The variant is found in BR-OV-HEREDIC panel(s). |